Since SARS-CoV-2 is highly infective, it is essential to prepare, store, handle and ship human samples to ensure that the people exposed to the biospecimens not only are familiar with the appropriate safety procedures for handling potentially infectious fluids or tissue samples but also are able and willing to implement them.
Read this paper to learn more about the possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry.